New — Free Peptide Starter Guide (2026): 13 chapters, 34 cited studies

Get it free
ToolsCompareAlpha-GPC vs Dermorphin

Alpha-GPC vs Dermorphin

Side-by-side comparison of key properties, dosing, and research.

Cognitive Enhancement
Alpha-GPC
Recovery & Repair
Dermorphin
Summary
Alpha-GPC is the most bioavailable form of choline, readily crossing the blood-brain barrier to rapidly increase acetylcholine levels. It enhances cognitive performance, supports GH secretion, and is used as an essential complement to many nootropic peptides (especially those that increase acetylcholine demand like Noopept and Dihexa).
Dermorphin is a naturally occurring heptapeptide opioid isolated from the skin of South American phyllomedusine frogs. It is one of the most potent endogenous mu-opioid receptor agonists known, approximately 30-40 times more potent than morphine by weight. Explored for pain management and fatigue modulation.
Half-Life
~4–6 hours
Estimated 30-60 minutes (longer than endorphins due to D-Ala)
Admin Route
Oral, SubQ
Subcutaneous (research), Intrathecal (research), Intranasal (research)
Research
Typical Dose
300–600 mg
Not established for human use; research doses vary widely
Frequency
1–2x daily
Not established
Key Benefits
  • Rapidly raises brain acetylcholine levels
  • Enhances memory formation and recall
  • Prevents headaches from nootropic peptides (choline donor)
  • Stimulates growth hormone secretion (modest)
  • Improves attention and processing speed
  • Neuroprotective in Alzheimer's and cognitive decline
  • Approved in Europe for Alzheimer's therapy
  • Enhances power output in athletes (pre-workout)
  • Potent analgesia superior to morphine on a per-weight basis
  • May reduce perception of fatigue in high-intensity activity
  • Longer-lasting than endogenous opioids due to D-amino acid substitution
  • Research tool for mu-opioid receptor pharmacology
  • Potential therapeutic application in refractory pain
Side Effects
  • Headache (paradoxically, from excess acetylcholine at very high doses)
  • Nausea at doses > 1200 mg
  • Dizziness
  • Fatigue at high doses
  • +1 more
  • High addiction and dependence potential (mu-opioid agonism)
  • Respiratory depression at high doses
  • Nausea, vomiting, constipation
  • Sedation and cognitive impairment
  • +2 more
Stacks With